🇺🇸 FDA

Company profile · Sponsor

InflaRx

InflaRx GmbH

ED35A25 · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

InflaRx (ED35A25) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED35A25
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. PREDNISOLONE, CORTISONE ACETATE, FLUDROCORTISONE, Gohibic, TRIAMCINOLONE, PREDNISONE, DEXAMETHASONE, HYDROCORTISONE, METHYLPREDNISOLONE, IFX-1 placebo is formulated as PBS (150 mM sodium chloride, 10 mM sodium phosphate, pH 7.0) with 0.05% polysorbate 80. IFX-1 placebo is diluted in sterile 0.9% sodium chloride to the required concentration and volume. This diluent is a commercial product not accompanying IFX-1 placebo., BETAMETHASONE

    InflaRx

    ulcerative pyoderma gangrenosum

    phase 3 small molecule active

    1 trial

  2. INF904

    InflaRx

    Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS)

    phase 2 small molecule active

    1 trial

  3. A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS

    InflaRx

    Not applicable, healthy volunteers

    phase 1 other active

    1 trial

  4. A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Formulations of INF904.

    InflaRx

    Not applicable, healthy volunteers

    phase 1 other active

    1 trial

Frequently asked questions

What is InflaRx?

InflaRx (ED35A25) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does InflaRx sponsor?

We track 4 ClinicalTrials.gov-linked programs for InflaRx, including PREDNISOLONE, CORTISONE ACETATE, FLUDROCORTISONE, Gohibic, TRIAMCINOLONE, PREDNISONE, DEXAMETHASONE, HYDROCORTISONE, METHYLPREDNISOLONE, IFX-1 placebo is formulated as PBS (150 mM sodium chloride, 10 mM sodium phosphate, pH 7.0) with 0.05% polysorbate 80. IFX-1 placebo is diluted in sterile 0.9% sodium chloride to the required concentration and volume. This diluent is a commercial product not accompanying IFX-1 placebo., BETAMETHASONE and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does InflaRx company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.